DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Del Mastro L, Mansutti M, Bisagni G. et al.
Benefit from letrozole as extended adjuvant therapy after sequential endocrine therapy: A randomized, phase III study of Gruppo Italiano Mammella (GIM). 2019 ASCO Annual Meeting; Abstr. 504.
We do not assume any responsibility for the contents of the web pages of other providers.